A61P 21 - Drugs for disorders of the muscular or neuromuscular system

Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2007
12/26/2007	CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/25/2007	US7312344 Dimeric isoflavones
12/25/2007	US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007	US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/25/2007	US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007	US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007	US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/21/2007	WO2007146313A1 Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
12/21/2007	WO2007146088A1 Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof
12/21/2007	WO2007146085A2 Creatine phosphate prodrugs, compositions and uses thereof
12/21/2007	WO2007143794A1 Formulation comprising whey protein and hydrolysates for improving muscle recovery
12/21/2007	CA2649982A1 Formulation comprising whey protein and hydrolysates for improving muscle recovery
12/20/2007	US20070293572 Anti-Fatigue Composition
12/20/2007	US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007	US20070292408 compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene
12/19/2007	EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007	EP1865944A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
12/19/2007	EP1497261B1 Phenethanolamine derivatives
12/19/2007	EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007	CN101088528A Chinese medicine for treating myophagism
12/18/2007	US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/18/2007	CA2489763C Pharmaceutical salts of reboxetine
12/18/2007	CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use
12/18/2007	CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer
12/13/2007	WO2007143660A1 Reducing muscle soreness with glucosamine compositions
12/13/2007	WO2007142325A1 Preventive or remedy for inflammatory disease
12/13/2007	WO2007141018A1 Therapeutic combination for painful medical conditions
12/13/2007	WO2007098106A3 Respiratory tract delivery of interferon-tau
12/13/2007	US20070287746 Use of Anti-Oxidant Compounds for Muscle Recovery
12/13/2007	US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007	US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007	CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease
12/13/2007	CA2652667A1 Therapeutic combination for painful medical conditions
12/12/2007	EP1864975A2 Novel compounds
12/12/2007	EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007	EP1309618B1 Leucine-based motif and clostridial neurotoxins
12/12/2007	EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals
12/12/2007	CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/12/2007	CN101084896A Atracurium freezing-dried composition
12/12/2007	CN100354000C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
12/12/2007	CN100353951C Medicine for treating muscular dystrophy and myasthenia gravis, and its prepn. method
12/11/2007	US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
12/11/2007	US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007	US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide
12/11/2007	US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis
12/11/2007	US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
12/06/2007	WO2007139128A1 Composition for inhibiting the secretion of creatine phosphokinase
12/06/2007	WO2007138994A1 Hsp90 inhibitor
12/06/2007	US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
12/06/2007	US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases
12/06/2007	CA2653319A1 Hsp90 inhibitor
12/05/2007	EP1862475A1 Polymer conjugates of neublastin and methods of using same
12/05/2007	EP1861080A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies
12/05/2007	CN101084009A Gh secretagogues and uses thereof
12/05/2007	CN101081865A Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof
12/05/2007	CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007	CN100352816C Nociceptin analogs
12/05/2007	CN100352807C Chemical compounds
12/05/2007	CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007	CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation
12/04/2007	US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/04/2007	US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007	US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007	CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007	CA2233315C Pharmaceutical compositions containing hydroximic acid derivatives
11/2007
11/29/2007	WO2007134867A2 Treating muscular disorders and improving muscular function
11/29/2007	WO2007104780A3 N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use
11/29/2007	WO2007074346A3 Modulation of wnt signalling pathways for treating nervous system disorders
11/29/2007	US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007	DE202007011042U1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate
11/28/2007	EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007	CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007	CN100351244C Bis-aromatic alkanols
11/27/2007	US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007	US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007	CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007	CA2309380C Viscous compositions containing carbon dioxide
11/22/2007	WO2007132888A1 Smooth muscle contraction inhibitor
11/22/2007	WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007	WO2007100695A9 Metabolic regulators and uses thereof
11/22/2007	WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007	WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007	US20070270462 8-hydroxyquinoline compounds for treating a polyglutamine (polyQ)-expansion disease
11/22/2007	US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007	DE102005014080B4 Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel Addition salts of tolperisone, processes for their manufacture, use thereof and pharmaceutical compositions containing them
11/21/2007	EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007	EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007	EP1855710A1 Muscle regeneration
11/21/2007	EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007	EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/20/2007	US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007	US7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/15/2007	WO2007130031A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007	WO2007129473A1 Bicyclic aryl derivative
11/15/2007	WO2007128465A1 Xanthone derivative for the treatment of muscular disorders
11/15/2007	WO2007085728A3 Composition containing several botulic toxins
11/15/2007	WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007	US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007	US20070265237 Pure rocuronium bromide
11/15/2007	US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents

1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 233